Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer
- Resource Type
- Article
- Source
- In
Computational Biology and Chemistry February 2019 78:290-296 - Subject
- Language
- ISSN
- 1476-9271